SonataSys-Logo_RGB

Transcervical Fibroid Ablation for Treatment of Symptomatic Uterine Fibroids

The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure to treat symptomatic uterine fibroids.

  • Delivers a breakthrough alternative to hysterectomy and myomectomy
  • Transcervical delivery avoids the peritoneal cavity and does not require general anesthesia
  • Treats most fibroid types including submucous, intramural, transmural, and subserous

SONATA Pivotal IDE Trial Results Through 3 Years1,2

1. Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas. Obstet Gynecol. 2019; 133:13-22.

2. Lukes A, Green MA. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata. J Gynecol Surg. 2020;36:5, 228-233.

Visit the Sonata Treatment Website

For more information about the Sonata System for patients and healthcare providers:

Indications and Safety Information

The Sonata System is intended for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.